Role of Genetic Mutations in Periodontitis Patients with Cardiovascular Diseases and Allied Ailments: A Systematic Review and Meta-analysis Authors: Pragathi Yatham, Mahendra Jaideep, V. Ramadevi, Asha L. Pogula, Panneerselvam Periasamy Published: 2024 ABSTRACT ABSTRACTBackground:Periodontal disease, a chronic inflammatory condition, has been increasingly associated with systemic health issues, particularly cardiovascular diseases. This systematic review and meta-analysis explores the role of genetic mutations in periodontitis patients with cardiovascular diseases and allied ailments.Methodology:Conducted a comprehensive search across databases including PubMed, EMBASE, and Cochrane Library to identify relevant studies on the association between genetic mutations, periodontal disease severity, and cardiovascular outcomes. Sixteen studies met the inclusion criteria, primarily comprising observational studies with varying levels of risk of bias.Results:Our analysis revealed that specific genetic mutations, such as those in TLR 2, TLR 4, NF-kB, and IL-4 genes, significantly increase the risk of periodontitis and exacerbate cardiovascular conditions like coronary artery disease, myocardial infarction, and stroke. These findings underscore the importance of integrating genetic screening into the management of periodontal and cardiovascular diseases. The results also emphasize the need for interdisciplinary collaboration between dental and medical professionals to develop personalized treatment strategies.Conclusion:In conclusion, genetic mutations play a pivotal role in the susceptibility and severity of periodontitis in patients with cardiovascular diseases. Understanding these genetic factors could lead to improved diagnostic tools and therapeutic approaches, addressing the dual burden of periodontal disease and cardiovascular ailments. Future research should focus on large-scale, longitudinal studies to further elucidate the molecular mechanisms and develop targeted interventions for these interconnected health issues. INTRODUCTION Periodontal disease, a chronic inflammatory condition affecting teeth’s supporting structures, is linked to systemic health issues. Genetic mutations may increase susceptibility, especially in patients with cardiovascular diseases and allied ailments, complicating diagnosis and management of these interconnected health issues.[1] Periodontal disease is linked to cardiovascular diseases, with genetic mutations and risk factors like diabetes and obesity potentially influencing inflammatory responses, complicating management in cardiovascular comorbidities.[2] Advances in genomics and personalized medicine reveal genetic predispositions in periodontal disease pathogenesis. These factors influence immune responses, tissue degradation, and inflammatory pathways. Integrating genetic assessments into disease management strategies helps understand disease susceptibility and progression in cardiovascular diseases and allied ailments.[34] The study explores the role of genetic mutations in periodontitis susceptibility and severity in patients with cardiovascular diseases. It suggests that understanding these genetic factors could improve diagnostic tools and therapeutic approaches, addressing the dual burden of periodontal disease and cardiovascular ailments. Additionally, genetic factors involved in inflammatory processes can influence the immune response to periodontal pathogens, potentially affecting disease outcomes and cardiovascular condition progression. METHODOLOGY The systematic review and meta-analysis of genetic mutations in periodontitis patients with cardiovascular diseases and associated conditions was conducted using electronic databases such as PubMed, EMBASE, and Cochrane Library. The search strategy involved a thorough exploration of available literature, including observational studies, clinical trials, and case–control studies that reported on genetic variations in relation to periodontitis severity and its association with cardiovascular disease outcomes. Data extraction was performed independently by two reviewers to ensure accuracy. The meta-analysis component involved a quantitative synthesis of the available data, using appropriate statistical methods to pool effect sizes and assess the overall strength of the relationship between genetic mutations and the risk of developing periodontitis in the context of cardiovascular diseases and allied conditions. Sensitivity analyses were conducted to evaluate the robustness of the findings across different study designs and populations. The study provides compelling evidence supporting the pivotal role of genetic mutations in the pathogenesis of periodontitis, particularly among individuals with comorbid cardiovascular diseases and allied conditions. This association potentially highlights the shared inflammatory pathways between these two conditions, necessitating a multifaceted approach to patient care that considers both periodontal and cardiovascular health factors in clinical practice. The findings underscore the importance of interdisciplinary collaboration between dental and medical professionals to address the dual burden of periodontal and cardiovascular diseases, with a focus on precision medicine and personalized treatment plans that consider the genetic un. SEARCH STRATEGY AND STUDY SELECTION A comprehensive literature search was conducted using databases like PubMed, EMBASE, and Cochrane Library to identify studies on the association between genetic mutations, periodontitis, and cardiovascular diseases. The search strategy included relevant keywords and Medical Subject Headings terms. The selected studies were subjected to rigorous quality assessment using the Cochrane risk of bias tool. This systematic review and meta-analysis aims to clarify the role of genetic mutations in periodontitis patients with cardiovascular diseases and allied ailments. The rigorous methodology enhances the reliability of the findings and provides insights for developing targeted intervention strategies for affected populations. The study aims to provide evidence-based conclusions on the role of genetic mutations in periodontitis patients with cardiovascular diseases. DATA EXTRACTION AND QUALITY ASSESSMENT The study extracted key data from selected studies, including study design, sample size, participant characteristics, genetic mutations, periodontal disease status, and cardiovascular disease diagnoses. The data was meticulously recorded to analyze associations between genetic mutations, periodontal disease severity, and cardiovascular disease prevalence. The quality of the studies was assessed using the Cochrane risk of bias tool. The data was synthesized using a random-effects meta-analysis model to account for heterogeneity and interstudy variability. RESULTS The study analyzed 270 studies, excluding duplicates, and found 53 relevant articles. After screening, only 39 met eligibility criteria, with 23 excluded due to language barriers. After removing 23 articles, 16 met inclusion and exclusion criteria, demonstrating relevance to the study’s objective. All studies were observational. A systematic review of 16 studies found a significant association between specific genetic mutations and periodontitis severity, particularly in patients with cardiovascular complications [Figure 1]. The analysis suggested that these genetic variations may exacerbate systemic conditions, reinforcing the link between periodontal disease and cardiovascular health risks. This highlights the importance of personalized disease management and prevention. PRISMA 2020 flow diagram A meta-analysis of studies on cardiovascular diseases (CVDs) found significant correlations between study designs, evaluation methods, and risk of bias (ROB). The [Table 1] studies, primarily using prospective or retrospective designs, had sample sizes ranging from 3,081 to 7,87,490 participants. Most used clinical methods, while a few used self-reported data. The outcomes measured included stroke, MI, CHD, hypertension, and atrial fibrillation. Most studies reported a critical ROB, indicating potential design or execution issues that could affect the reliability of the findings. Self-reporting methods also had a serious ROB, reflecting limitations and potential biases. Follow-up durations varied, with some tracking participants for up to 37 years and others for 5 to 16 years. The findings emphasize the importance of methodological rigor in evaluating cardiovascular outcomes, with the critical ROB indicating the need for cautious interpretation of results, especially when self-reported data is involved.[5] Table 1Study characteristics of the included studiesStudyStudy designSample sizeMethod of evaluationResultsFollow-upROBYu et al., 2015Prospective39,863Self-reportStroke + MI16CriticalSen et al., 2018Retrospective6,736ClinicalStroke15SeriousRivas-Tumanyan, et al., 2012Prospective31,543Self-reportHypertension20CriticalNoguchi et al., 2014Prospective3,081Self-reportMI5SeriousMucci et al., 2009Prospective15,273Self-reportCHD + stroke37SeriousLin et al., 2019Retrospective1,61,923ClinicalStroke10CriticalLee, Hu, Chou, and Chu, 2015aRetrospective7,20,343ClinicalMI10CriticalLee et al., 2017Retrospective3,54,850ClinicalStroke + MI12CriticalLee et al., 2013aRetrospective7,19,436ClinicalStroke10CriticalLaMonte et al., 2017Prospective57,001Self-reportCHD + stroke12CriticalJoshy et al., 2016Prospective1,72,630Self-reportCHD + stroke5SeriousHolmlund et al., 2017bProspective8,999ClinicalAny CVD34CriticalHansen, Egeberg, Holmstrup, and Hansen, 2016Prospective1,00,694ClinicalStroke + MI15CriticalChou et al., 2015aRetrospective27,146ClinicalAny CVD9CriticalChen, Lin, Chen, and Chen, 2016Retrospective7,87,490ClinicalAF10CriticalBatty et al., 2018Prospective6,26,106ClinicalCHD21Serious Study characteristics of the included studies A meta-analysis of 16 studies found that individuals with mutations in TLR 2, TLR 4, NFbK, and IL 4 genes were at a six-fold increased risk of developing periodontitis. These mutations also increased the risk of developing cardiovascular conditions like coronary artery disease, myocardial infarction, and stroke. The study highlighted the need for integrated healthcare strategies that address both periodontal health and cardiovascular disease management. Cytokine gene polymorphisms were linked to increased inflammatory responses and periodontal tissue destruction in patients with cardiovascular comorbidities. Genetic screening could aid in risk stratification and personalized treatment plans to mitigate the negative effects of periodontitis on cardiovascular health outcomes. DISCUSSION The meta-analysis of studies on cardiovascular diseases reveals significant relationships between study designs, evaluation methods, and risk of bias. Most studies use clinical evaluations, with some relying on self-reported data. The critical ROB suggests potential study design and execution concerns, while large sample sizes contribute to overall findings.[6] Genetic mutations play a crucial role in periodontitis, especially in patients with cardiovascular diseases, enabling targeted therapeutic interventions and improved health outcomes.[7] Genetic mutations play a crucial role in periodontitis, especially in patients with cardiovascular diseases. Future research should explore molecular mechanisms and preventive strategies to improve management and patient outcomes. Integrating dental and medical care is essential.[6] Future research should focus on longitudinal studies and large-scale cohorts to understand the temporal relationships between genetic mutations and periodontal and cardiovascular diseases. This will enable the development of personalized preventive and therapeutic strategies.[1] The study highlights the importance of exploring genetic influences to identify novel biomarkers and therapeutic targets for managing periodontitis and cardiovascular diseases. It emphasizes the need for an interdisciplinary approach to health care, translating genetic research into practical applications. Addressing modifiable risk factors, such as lifestyle and behavioral changes, is crucial for managing these conditions. This holistic approach addresses both immediate clinical needs and public health objectives, emphasizing early intervention and continuous care. Collaboration among dental, medical, and public health professionals can enhance preventive and therapeutic strategies. Community-based programs can also impact preventive measures, potentially reducing the incidence of periodontitis and associated complications.[28] CONCLUSION Genetic mutations significantly increase periodontitis risk and severity, especially in cardiovascular disease patients. This suggests that genetic screening and integrated healthcare approaches could lead to personalized treatments and improved clinical outcomes. Ethical approval This systematic review of published literature does not require any ethical approval. Conflicts of interest There are no conflicts of interest.